Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1
Article in Vaccines (April 2024)
The most recent citing publications are shown below. View all 565 publications that cite this research output on Dimensions.
Article in Vaccines (April 2024)
Article in Antibodies (April 2024)
Article in Frontiers in Cellular and Infection Microbiology (April 2024)